Baker Botts (Washington)

Mark J. Botti

Baker Botts (Washington)
Lawyer (Partner)

Mark Botti advises clients and represents them on the full spectrum of antitrust matters, including government investigations, mergers and acquisitions, joint ventures, government and private litigation, and competition policy matters. His work has spanned all sectors of the economy, including healthcare, managed care and health information technology; financial services, including electronic payment systems; intellectual property and high technology matters; forestry products; consumer products; national defense; media and entertainment; and insurance. Mark served for 13 years at the U.S. Department of Justice in various litigation and leadership positions within the Antitrust Division. Mark litigated and supervised complex antitrust matters, mergers and acquisitions, monopolization cases and joint ventures. He consulted regularly with international antitrust enforcement authorities on investigatory matters and on the development of their merger and other antitrust regulations and practices. Mark was the Division official who directly oversaw the extensive hearings held by the Division and the Federal Trade Commission on healthcare during the years 2004-2005, as well as drafted the agency’s joint seminal report, "Improving Health Care: A Dose of Competition."

Linked authors

Baker Botts (Brussels)
Baker Botts
Baker Botts (London)
Baker Botts (Washington)
Baker Botts (Washington)

Articles

196 Bulletin

Kelly M. Cleary, Mark J. Botti The US DoJ seeks divestiture and conduct remedies after breaking new ground by analyzing the anticompetitive impact on the Medicare Advantage system (UnitedHealth / Sierra Health)

196

On February 25, 2008, UnitedHealth Group (United) and Sierra Health Services, Inc. (Sierra) announced that they would proceed with a merger whereby United will acquire all outstanding shares of Sierra in a transaction valued at $2.6 billion. Their statement came shortly after the United States (...)

Send a message